Fair to say that if this is indeed a takeover, then the directors do have a fiduciary duty to ensure that they get the best price and that any low ball offer should be rejected, as no doubt it would be the shareholders in general.
Given the stream of exploration results to come, any suitor would have to pay overs, as any negotiator would argue for a higher price based purely on what is expected to come.
- Forums
- ASX - By Stock
- EAR
- Ann: Trading Halt
Ann: Trading Halt, page-119
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EAR (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online